Kintara (KTRA) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan
Kintara Therapeutics (KTRA) is striving for high scalability by developing treatments for resistant tumors with the potential for software-like profits through alliances with pharma behemoths. A stable investor pool supports the company during its transition to cellular vaccines. This chart reflects an asset value of 0.00, while Kintara Therapeutics (KTRA) minimizes costs by outsourcing production and testing to third-party contractors.
KTRA (Kintara Therapeutics Inc): rincian analitis lan laporan miturut indikator
- rega saham lan target rega konsensus:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data utang lan likuiditas:
Utang marang Ekuitas Kintara Therapeutics|KTRA - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Kintara|KTRA - Utang perusahaan|Rasio utang marang kapitalisasi buku Kintara Pharma|KTRA - Utang jangka dawa|Utang jangka cendhak perusahaan Kintara Therapeutics|Indikator likuiditas cepet kintara.com
- data bathi bisnis lan rasio investasi:
KTRA - Penghasilan resik perusahaan|Bathi mangsa ngarep Kintara Therapeutics|KTRA - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Kintara Therapeutics|KTRA - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Kintara Therapeutics Inc|KTRA - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Kintara Therapeutics|KTRA - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan kintara.com|KTRA - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Kintara Therapeutics
- indikator dodolan lan pendapatan:
Ringkesan analitik perusahaan:KTRA (Kintara Therapeutics Inc)
The merger of Kintara Therapeutics (KTRA) with an oncology platform mitigates the risks of a single-product model, transforming the asset structure. The EV/EBITDA trend on this chart allows for an assessment of this rebalancing efficiency relative to market capitalization and debt. This metric measures the business payback period via operating profit before interest, taxes, depreciation, and amortization, determining the fair value of shares within the high-risk biotech asset category.
Analisis pesaing
Incyte Corporation - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|hutch-med.com (HCM) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|NUVB - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Day One Biopharmaceuticals, Inc.|Monopar Therapeutics (MNPR) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi operasional sadurunge panyusutan INBX|IMAB (i-mabbiopharma.com) - Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan fennecpharma.com (FENC)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Heron Therapeutics (HRTX)|NVCT - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Coherus BioSciences, Inc CHRS|Corbus Pharmaceuticals, Inc. - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|CRDF - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BeyondSpring Inc.|BCAB: Pangali EV/EBITDA|Pangali nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Lixte Biotechnology Holdings LIXT|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CTXR|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Cellectar Biosciences CLRB|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BLRX (BioLineRx Ltd.)|CANF (Can-Fite BioPharma Ltd.) - Nilai bisnis marang bathi operasional sadurunge panyusutan|Aprea Therapeutics, Inc. - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan KZIA (Kazia)|Silexion Therapeutics - Pangali EV/EBITDA|Nilai bisnis marang bathi operasional sadurunge panyusutan NCNA (nucana.com)|CMRX: Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan cyclacel.com (CYCC)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan g1therapeutics.com|KRON: Nilai bisnis marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA ONCT|Pangali EV/EBITDA Portage Biotech Corp (PRTG)
